A Randomized Study to Compare the Effects of Once-Weekly Dulaglutide Injection and Once-Daily Glimepiride on Glucose Fluctuation of Type 2 Diabetes Mellitus Patients: A 26-Week Follow-Up.
Hui-Qin LiXiaohua XuJie WangXiao-Cen KongMaoyuan ChenTing JingZhiying ZhangGuoping YinXiaomei LiuYun HuLei YeXiao-Fei SuJian-Hua MaPublished in: Journal of diabetes research (2019)
Once-weekly dulaglutide injection has the same effectiveness as daily glimepiride on lowering blood glucose and decreasing oxidation stress and inflammation and is more effective in controlling glucose fluctuation as compared with glimepiride. This trial is registered with ClinicalTrials.gov NCT01644500.
Keyphrases
- type diabetes
- blood glucose
- glycemic control
- end stage renal disease
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- newly diagnosed
- physical activity
- oxidative stress
- clinical trial
- systematic review
- ultrasound guided
- peritoneal dialysis
- study protocol
- adipose tissue
- metabolic syndrome
- nitric oxide
- heat stress
- stress induced
- patient reported